Open AccessModel of Polymicrobial Peritonitis That Induces the Proinflammatory and Immunosuppressive Phases of Sepsis
Author(s) -
Gabriela Barrera,
Verónica Inés Landoni,
Daiana Martire-Greco,
Paula Chiarella,
Roberto P. Meiss,
Sonia Gómez,
Fernanda Alves-Rosa,
Bárbara Rearte,
Martı́n A. Isturiz,
Marina S. Palermo,
Gabriela Fernández
Publication year - 2011
Publication title -
infection and immunity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 220
eISSN - 1070-6313
pISSN - 0019-9567
DOI - 10.1128/iai.01127-10
Subject(s) - sepsis , proinflammatory cytokine , immunology , immune system , leukocytosis , biology , bacteremia , peritonitis , leukopenia , innate immune system , inflammation , systemic inflammatory response syndrome , medicine , antibiotics , chemotherapy , microbiology and biotechnology
Severe sepsis is associated with early release of inflammatory mediators that contribute to the morbidity and mortality observed during the first stages of this syndrome. Although sepsis is a deadly, acute disease, high mortality rates have been observed in patients displaying evidence of sepsis-induced immune deactivation. Although the contribution of experimental models to the knowledge of pathophysiological and therapeutic aspects of human sepsis is undeniable, most of the current studies using animal models have focused on the acute, proinflammatory phase. We developed a murine model that reproduces the early acute phases but also the long-term consequences of human sepsis. We induced polymicrobial acute peritonitis (AP) by establishing a surgical connection between the cecum and the peritoneum, allowing the exit of intestinal bacteria. Using this model, we observed an acute phase with high mortality, leukopenia, increased interleukin-6 levels, bacteremia, and neutrophil activation. A peak of leukocytosis on day 9 or 10 revealed the persistence of the infection within the lung and liver, with inflammatory hepatic damage being shown by histological examination. Long-term (20 days) derangements in both innate and adaptive immune responses were found, as demonstrated by impaired systemic tumor necrosis factor alpha production in response to an inflammatory stimulus; a decreased primary humoral immune response and T cell proliferation, associated with an increased number of myeloid suppressor cells (Gr-1+ CD11b+ ) in the spleen; and a low clearance capacity. This model provides a good approach to attempt novel therapeutic interventions directed to augmenting host immunity during late sepsis.